Pre-Leukemia
Showing 1 - 25 of >10,000
Acute Myeloid Leukemia, Pediatric Cancer Trial in Boston (Uproleselan, Fludarabine, Clofarabine)
Recruiting
- Acute Myeloid Leukemia
- Pediatric Cancer
- Uproleselan
- +3 more
-
Boston, Massachusetts
- +1 more
Oct 24, 2022
Severe COVID-19 Infection in CLL or B-NHL Who Received
Not yet recruiting
- Chronic Lymphocytic Leukemia
- +2 more
- (no location specified)
Apr 6, 2023
Parental Perception of Their Child's Emotional Quality of Life
Not yet recruiting
- Acute Lymphoblastic Leukemia, Pediatric
- Self-report questionnaires (only for parents)
- +2 more
- (no location specified)
Oct 24, 2023
Multiple Myeloma, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Charlottesville (Pre-biotic foods/drinks)
Completed
- Multiple Myeloma
- +11 more
- Pre-biotic foods/drinks
-
Charlottesville, VirginiaUniversity of Virginia
Jan 2, 2023
B-cell Adult Acute Lymphoblastic Leukemia, Stem Cell Leukemia, Minimal Residual Disease Trial in Vancouver, Halifax
Terminated
- B-cell Adult Acute Lymphoblastic Leukemia
- +2 more
- blinatumomab
-
Vancouver, British Columbia, Canada
- +2 more
Feb 3, 2022
Bortezomib, Acute Myeloid Leukemia Trial in Wuhan (DAG pre-excitation regimen with Bortezomib)
Recruiting
- Bortezomib
- Acute Myeloid Leukemia
- DAG pre-excitation regimen with Bortezomib
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jul 31, 2023
Prophylactic HQP1351 Therapy, Third Generation TKI Trial in Guanzhou (HQP1351( Olverembatinib dimesylate))
Withdrawn
- Prophylactic HQP1351 Therapy
- Third Generation TKI
- HQP1351( Olverembatinib dimesylate)
-
Guanzhou, ChinaDepartment of Hematology, Nanfang Hospital, Southern Medical Uni
Jan 16, 2023
Childhood Lymphoblastic Lymphoma Trial in Taipei (TVG)
Recruiting
- Childhood Lymphoblastic Lymphoma
- TVG
-
Taipei, TaiwanNational Yang-Ming University
Aug 30, 2021
Myelodysplastic Syndrome, Myeloproliferative Tumors, Chronic Myelomonocytic Leukemia Trial in United States (other, drug,
Recruiting
- Myelodysplastic Syndrome
- +4 more
- Geriatric assessment (GA) pre-transplant
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Aug 24, 2022
Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Philadelphia (Palbociclib, Tazemetostat,
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Refractory Acute Myeloid Leukemia
- Palbociclib
- +4 more
-
Philadelphia, PennsylvaniaThomas Jefferson University Hospital
Jan 13, 2023
Multiple Myeloma, Solitary Plasmacytoma, Amyloidosis Trial in Milano (RITA (App))
Recruiting
- Multiple Myeloma
- +13 more
- RITA (App)
-
Milano, ItalyASST Santi Paolo e Carlo - SSD Ematologia - Neoplasie Ematologic
Jul 6, 2022
Bio-CAR-T BS Study
Recruiting
- Diffuse Large B Cell Lymphoma (DLBCL)
- +2 more
-
Brescia, ItalyASST Spedali Civili di Brescia
May 5, 2022
Acute Leukemia, Immune Deficiency Disorder, Congenital Hematological Disorder Trial in Rochester (radiation, drug, procedure)
Recruiting
- Acute Leukemia
- +9 more
- Total Body Irradiation 1200 cGy
- +7 more
-
Rochester, New YorkWilmot Cancer Institute
Jun 20, 2022
Pre-existing Kinase Domain Mutations in Ph-positive Leukemias
Recruiting
- Leukemia
-
Vienna, AustriaMedical Universitiy of Vienna
Mar 23, 2021
Chronic Myeloid Leukemia Trial in Germany, Netherlands (TKI discontinuation, nilotinib)
Active, not recruiting
- Chronic Myeloid Leukemia
- TKI discontinuation
- nilotinib
-
Freiburg, Baden-Württemberg, Germany
- +14 more
Nov 4, 2021
Philadelphia-Negative ALL, High-Risk Cancer Trial in Israel (Blinatumomab)
Recruiting
- Philadelphia-Negative ALL
- High-Risk Cancer
-
Haifa, Israel
- +3 more
May 6, 2021
B-cell Acute Lymphoblastic Leukemia Trial in United States (NGS-MRD, Myeloablative allogeneic HCT with a non-TBI conditioning
Recruiting
- B-cell Acute Lymphoblastic Leukemia
- NGS-MRD
- Myeloablative allogeneic HCT with a non-TBI conditioning regimen
-
Birmingham, Alabama
- +23 more
Aug 20, 2021
Leukemia, Lymphocytic, Chronic, B-Cell Trial in Duarte, Boston, Portland (BI 836826, Ibrutinib)
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- BI 836826
- Ibrutinib
-
Duarte, California
- +2 more
Sep 8, 2020
Hb A1C Pre and Post Confinement in Latin American Type 1
Not yet recruiting
- Type1diabetes
- Childhood ALL
-
Buenos Aires, ArgentinaValeria Hirschler
Nov 17, 2020
Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,
Completed
- Myelodysplastic Syndrome (MDS)
- +6 more
- Fludarabine
- +15 more
-
Gainesville, Florida
- +10 more
Nov 30, 2020
Stem Cell Transplant Complications, Leukemia, Myeloid, Acute, Leukemia Relapse Trial in Beijing (Decitabine, mBU/CY and ATG,
Recruiting
- Stem Cell Transplant Complications
- +2 more
- Decitabine
- +2 more
-
Beijing, Beijing, ChinaPeking University Institute of Hematology,Beijing
Mar 9, 2020
Acute Myeloid Leukemia, MDS Trial in Basel (NK-DLI)
Recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndromes
- NK-DLI
-
Basel, SwitzerlandUniversity Hospital Basel
Dec 1, 2020
Collecting and Storing Tissue From Young Patients With Cancer
Recruiting
- Acute Lymphoblastic Leukemia
- +13 more
- Cytology Specimen Collection Procedure
- Laboratory Biomarker Analysis
-
Birmingham, Alabama
- +68 more
Aug 4, 2022
Acute Lymphoblastic Leukemia, Adult Trial in Mexico City (Gemcitabine, Busulfan, Cyclophosphamide)
Unknown status
- Acute Lymphoblastic Leukemia, Adult
- Gemcitabine
- +3 more
-
Mexico City, Distrito Federal, MexicoInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubi
Jan 10, 2020